← Back to guidelines
Cardiology141 papers

Megaloblastic anemia of premature infant

Last edited: 4/14/2026

Overview

Megaloblastic anemia in premature infants is characterized by ineffective hematopoiesis, often due to deficiencies in vitamin B12 or folate, leading to macrocytic anemia, megaloblastic changes in bone marrow, and potential neurological complications 345.

Diagnosis

  • Clinical Presentation: Symptoms may include pallor, lethargy, feeding difficulties, and developmental delays 3.
  • Laboratory Tests: Elevated mean corpuscular volume (MCV), low hemoglobin levels, and megaloblastic changes on bone marrow examination 34.
  • Nutritional Assessment: Evaluate levels of vitamin B12 and folate to identify deficiencies 34.
  • Management

  • Vitamin Supplementation: Administer parenteral or enteral vitamin B12 and folate supplementation as needed, tailored to the infant's specific deficiencies 34.
  • Nutritional Support: Ensure adequate intake of fortified breast milk or specialized preterm infant formulas to prevent nutrient deficiencies 3.
  • Monitoring: Regular monitoring of hematologic parameters and nutritional status to guide treatment adjustments 34.
  • Special Populations

  • Premature Infants: Nutritional deficiencies, particularly in fat-soluble vitamins and trace elements, are critical concerns requiring meticulous monitoring and supplementation 34.
  • Key Recommendations

  • Supplement with Vitamin B12 and Folate: Initiate supplementation based on laboratory-confirmed deficiencies to correct megaloblastic anemia (Evidence: Moderate 34).
  • Use Fortified Nutritional Formulas: Employ fortified breast milk or specialized preterm infant formulas to prevent nutrient deficiencies from birth (Evidence: Moderate 3).
  • Regular Monitoring of Nutritional Status: Conduct frequent assessments of hematologic parameters and nutritional levels to ensure appropriate growth and development (Evidence: Expert opinion 3).
  • References

    1 Castello C. ["The Nidcap gave me the impression of having a fairer and more objective perception of the child"]. Soins. Pediatrie, puericulture 2024. link 2 Dunn PM. Arvo Ylppö (1887-1992): pioneer of Finnish paediatrics. Archives of disease in childhood. Fetal and neonatal edition 2007. link 3 . Nutrient needs and feeding of premature infants. Nutrition Committee, Canadian Paediatric Society. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1995. link 4 Lockitch G. Perinatal and pediatric nutrition. Clinics in laboratory medicine 1993. link 5 Rowe JC, Carey DE. Phosphorus deficiency syndrome in very low birth weight infants. Pediatric clinics of North America 1987. link36299-x) 6 Andrew M, Massicotte-Nolan P, Mitchell L, Cassidy K. Dysfunctional antithrombin III in sick premature infants. Pediatric research 1985. link

    Original source

    1. [1]
    2. [2]
      Arvo Ylppö (1887-1992): pioneer of Finnish paediatrics.Dunn PM Archives of disease in childhood. Fetal and neonatal edition (2007)
    3. [3]
      Nutrient needs and feeding of premature infants. Nutrition Committee, Canadian Paediatric Society. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne (1995)
    4. [4]
      Perinatal and pediatric nutrition.Lockitch G Clinics in laboratory medicine (1993)
    5. [5]
      Phosphorus deficiency syndrome in very low birth weight infants.Rowe JC, Carey DE Pediatric clinics of North America (1987)
    6. [6]
      Dysfunctional antithrombin III in sick premature infants.Andrew M, Massicotte-Nolan P, Mitchell L, Cassidy K Pediatric research (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG